Leap Therapeutics's total assets for Q1 2025 were $34.88M, a decrease of -29.00% from the previous quarter. LPTX total liabilities were $14.04M for the fiscal quarter, a -0.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.